HQH - Share In Healthcare And Biotech Gains With 12% Yield From This Tekla Fund
Co-produced with PendragonY for High Dividend Opportunities
Defensive Nature of Healthcare and Biotech Stocks
The healthcare and biotech sectors should play a role in every balanced portfolio, not only because they provide diversity, but also because of their fast growth, which is generally not dependent on the state of the economy. Companies in this sector are able to increase their revenues even during uncertain times, such as a recession. These are deemed as non-cyclical stocks, so they are not as much affected during economic downturns.
Why a biotechnology fund for an income investor?
The biotechnology